HS-10504

DRUG2 trials

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Conditions

Locally Advanced or Metastatic NSCLCLung Cancer

Phase 1

A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)

RecruitingNCT06461156

Jiangsu Hansoh Pharmaceutical Co., Ltd.Locally Advanced or Metastatic NSCLC

Start: 2025-07-22End: 2027-03-31Target: 230Updated: 2025-09-17

A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

Not yet recruitingNCT07414953

Jiangsu Hansoh Pharmaceutical Co., Ltd.Lung Cancer

Start: 2026-03-30End: 2028-11-30Target: 400Updated: 2026-02-17